Position in GRFS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,027,200
-$5,111,800 QoQ
Shares Held
1,840,000
-5.2% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 164 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORGES BANK holds $48,449,655,630 across 13 Drug Manufacturers - General names. GRFS ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,471,413 | $13,759,158,041 | |
| 2 | JNJ |
Johnson & Johnson
|
31,825,084 | $8,082,616,583 | |
| 3 | ABBV |
AbbVie Inc.
|
25,554,538 | $6,430,543,942 | |
| 4 | AZN |
Astrazeneca PLC
|
33,864,172 | $6,421,324,294 | |
| 5 | MRK |
Merck & Co., Inc.
|
36,983,784 | $4,752,416,244 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
21,965,555 | $2,775,128,218 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,866,658 | $2,124,256,833 | |
| 8 | AMGN |
Amgen Inc
|
5,625,584 | $2,037,136,478 |
All Filings in GRFS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,027,200 | 1,840,000 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $18,139,000 | 1,940,000 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $17,537,600 | 1,940,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,793,400 | 1,940,000 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $14,433,600 | 1,940,000 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $17,227,200 | 1,940,000 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $20,869,694 | 3,307,400 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,103,105 | 2,260,944 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $26,136,512 | 2,260,944 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $20,665,028 | 2,260,944 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $20,710,247 | 2,260,944 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $16,663,157 | 2,260,944 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $19,218,024 | 2,260,944 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $19,613,421 | 3,183,997 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $50,478,393 | 4,249,023 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $40,654,821 | 3,480,721 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $38,958,554 | 3,469,150 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $50,684,281 | 3,469,150 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $61,286,463 | 3,532,361 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $61,074,521 | 3,532,361 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $65,136,736 | 3,532,361 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $65,063,315 | 3,750,047 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $54,988,000 | 3,014,693 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $60,715,917 | 3,014,693 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||